Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
TSATSIS v. ORCHID CELLMARK, INC. et al
Case Number:
3:11-cv-02508
Court:
Nature of Suit:
Multi Party Litigation:
Class Action
Judge:
Firms
Companies
Sectors & Industries:
-
July 13, 2011
Orchid Shareholder Drops Suit Over $85M LabCorp Deal
A New Jersey federal court dismissed a proposed shareholder class action Wednesday that opposed Laboratory Corp. of America Holdings' $85 million buyout of DNA testing company Orchid Cellmark Inc.
-
May 04, 2011
Investor Tries To Stop LabCorp's $85M Orchid Buyout
Laboratory Corp. of America Holdings' plan to buy DNA testing company Orchid Cellmark Inc. for $85 million spurred a shareholder class action in New Jersey on Monday claiming the expedited deal is grossly undervalued.